SearcharxivSearch

arXiv subjects

Arvind Rao

Publications and source records attributed to Arvind Rao.

At least 19 recordsLinked to original sources

Agents' Last Exam

Recent AI systems have achieved strong results on a wide range of benchmarks, yet these gains have not translated into economically meaningful deployment across many professional domains. We argue that this gap is largely an evaluation problem: widely used benchmarks lack sustained performance measurement on real and economically valuable workflows. This paper introduces Agents' Last Exam (ALE), a benchmark designed to evaluate AI agents on long horizon, economically valuable, real world tasks with verifiable outcomes. Developed in collaboration with 250+ industry experts, ALE covers non-physical industries defined with reference to O*NET / SOC 2018 (the U.S. federal occupational taxonomy). It is organized around a task taxonomy with 55 sub fields grouped into 13 industry clusters covering 1K+ tasks. Current results show that the hardest tier remains far from saturated: across mainstream harness and backbone configurations, the average full pass rate is below 1%. ALE is designed as a living benchmark: its task pool grows continuously as new workflows and industries are onboarded. More broadly, ALE is intended not merely as another leaderboard, but as an instrument for closing the gap between benchmark success and GDP relevant impact.

cs.AI

Quantum Hamiltonian Learning using Time-Resolved Measurement Data and its Application to Gene Regulatory Network Inference

We present a new Hamiltonian-learning framework based on time-resolved measurement data from a fixed local IC-POVM and its application to inferring gene regulatory networks. We introduce the quantum Hamiltonian-based gene-expression model (QHGM), in which gene interactions are encoded as a parameterized Hamiltonian that governs gene expression evolution over pseudotime. We derive finite-sample recovery guarantees and establish upper bounds on the number of time and measurement samples required for accurate parameter estimation with high probability, scaling polynomially with system size. To recover the QHGM parameters, we develop a scalable variational learning algorithm based on empirical risk minimization. Our method recovers network structure efficiently on synthetic benchmarks and reveals novel, biologically plausible regulatory connections in Glioblastoma single-cell RNA sequencing data, highlighting its potential in cancer research. This framework opens new directions for applying quantum-like modeling to biological systems beyond the limits of classical inference.

quant-ph

Efficient inference of dynamic gene regulatory networks using discrete penalty

Gene regulatory networks (GRNs) orchestrate cellular decision making and survival strategies. Inferring the structure of these networks from high-dimensional transcriptomics data is a central challenge in systems biology. Traditional approaches to GRN inference, such as the graphical lasso and its joint extensions, rely on $\ell_1$ penalty to induce sparsity but can bias network recovery and require extensive hyperparameter tuning. Here, we present a scalable framework for the joint inference of dynamic GRNs using a discrete $\ell_0$ penalty, enabling direct and unbiased control over network sparsity. Leveraging recent algorithmic advances, we efficiently solve the resulting mixed-integer optimization problem for populations structured as arbitrary tree hypergraphs, accommodating both continuous and categorical distinctions among biological samples. After validating our method on synthetic benchmarks, we apply it to single-cell and spatial transcriptomics data from glioblastoma (GBM) patient tumors. Our approach reconstructs gene networks across tumor clusters, maps network rewiring along hypoxia gradients, and reveals niche-specific differences between primary and recurrent tumors. By providing a robust and interpretable tool for GRN inference in complex tissues, our work facilitates high-resolution dissection of tumor heterogeneity and adaptation, with broad applicability to emerging large-scale transcriptomic datasets.

stat.AP

QubitLens: An Interactive Learning Tool for Quantum State Tomography

Quantum state tomography is a fundamental task in quantum computing, involving the reconstruction of an unknown quantum state from measurement outcomes. Although essential, it is typically introduced at the graduate level due to its reliance on advanced concepts such as the density matrix formalism, tensor product structures, and partial trace operations. This complexity often creates a barrier for students and early learners. In this work, we introduce QubitLens, an interactive visualization tool designed to make quantum state tomography more accessible and intuitive. QubitLens leverages maximum likelihood estimation (MLE), a classical statistical method, to estimate pure quantum states from projective measurement outcomes in the X, Y, and Z bases. The tool emphasizes conceptual clarity through visual representations, including Bloch sphere plots of true and reconstructed qubit states, bar charts comparing parameter estimates, and fidelity gauges that quantify reconstruction accuracy. QubitLens offers a hands-on approach to learning quantum tomography without requiring deep prior knowledge of density matrices or optimization theory. The tool supports both single- and multi-qubit systems and is intended to bridge the gap between theory and practice in quantum computing education.

quant-ph

Joint Modeling of Spatial Dependencies Across Multiple Subjects in Multiplexed Tissue Imaging

The tumor microenvironment (TME) is a spatially heterogeneous ecosystem where cellular interactions shape tumor progression and response to therapy. Multiplexed imaging technologies enable high-resolution spatial characterization of the TME, yet statistical methods for analyzing multi-subject spatial tissue data remain limited. We propose a Bayesian hierarchical model for inferring spatial dependencies in multiplexed imaging datasets across multiple subjects. Our model represents the TME as a multivariate log-Gaussian Cox process, where spatial intensity functions of different cell types are governed by a latent multivariate Gaussian process. By pooling information across subjects, we estimate spatial correlation functions that capture within-type and cross-type dependencies, enabling interpretable inference about disease-specific cellular organization. We validate our method using simulations, demonstrating robustness to latent factor specification and spatial resolution. We apply our approach to two multiplexed imaging datasets: pancreatic cancer and colorectal cancer, revealing distinct spatial organization patterns across disease subtypes and highlighting tumor-immune interactions that differentiate immune-permissive and immune-exclusive microenvironments. These findings provide insight into mechanisms of immune evasion and may inform novel therapeutic strategies. Our approach offers a principled framework for modeling spatial dependencies in multi-subject data, with broader applicability to spatially resolved omics and imaging studies. An R package, available online, implements our methods.

stat.AP

A Two-Stage Approach for Segmenting Spatial Point Patterns Applied to Multiplex Imaging

Recent advances in multiplex imaging have enabled researchers to locate different types of cells within a tissue sample. This is especially relevant for tumor immunology, as clinical regimes corresponding to different stages of disease or responses to treatment may manifest as different spatial arrangements of tumor and immune cells. Spatial point pattern modeling can be used to partition multiplex tissue images according to these regimes. To this end, we propose a two-stage approach: first, local intensities and pair correlation functions are estimated from the spatial point pattern of cells within each image, and the pair correlation functions are reduced in dimension via spectral decomposition of the covariance function. Second, the estimates are clustered in a Bayesian hierarchical model with spatially-dependent cluster labels. The clusters correspond to regimes of interest that are present across subjects; the cluster labels segment the spatial point patterns according to those regimes. Through Markov Chain Monte Carlo sampling, we jointly estimate and quantify uncertainty in the cluster assignment and spatial characteristics of each cluster. Simulations demonstrate the performance of the method, and it is applied to a set of multiplex immunofluorescence images of diseased pancreatic tissue.

stat.ME

Spatially Structured Regression for Non-conformable Spaces: Integrating Pathology Imaging and Genomics Data in Cancer

The spatial composition and cellular heterogeneity of the tumor microenvironment plays a critical role in cancer development and progression. High-definition pathology imaging of tumor biopsies provide a high-resolution view of the spatial organization of different types of cells. This allows for systematic assessment of intra- and inter-patient spatial cellular interactions and heterogeneity by integrating accompanying patient-level genomics data. However, joint modeling across tumor biopsies presents unique challenges due to non-conformability (lack of a common spatial domain across biopsies) as well as high-dimensionality. To address this problem, we propose the Dual random effect and main effect selection model for Spatially structured regression model (DreameSpase). DreameSpase employs a Bayesian variable selection framework that facilitates the assessment of spatial heterogeneity with respect to covariates both within (through fixed effects) and between spaces (through spatial random effects) for non-conformable spatial domains. We demonstrate the efficacy of DreameSpase via simulations and integrative analyses of pathology imaging and gene expression data obtained from $335$ melanoma biopsies. Our findings confirm several existing relationships, e.g. neutrophil genes being associated with both inter- and intra-patient spatial heterogeneity, as well as discovering novel associations. We also provide freely available and computationally efficient software for implementing DreameSpase.

stat.AP

Multimodal Machine Learning in Image-Based and Clinical Biomedicine: Survey and Prospects

Machine learning (ML) applications in medical artificial intelligence (AI) systems have shifted from traditional and statistical methods to increasing application of deep learning models. This survey navigates the current landscape of multimodal ML, focusing on its profound impact on medical image analysis and clinical decision support systems. Emphasizing challenges and innovations in addressing multimodal representation, fusion, translation, alignment, and co-learning, the paper explores the transformative potential of multimodal models for clinical predictions. It also highlights the need for principled assessments and practical implementation of such models, bringing attention to the dynamics between decision support systems and healthcare providers and personnel. Despite advancements, challenges such as data biases and the scarcity of "big data" in many biomedical domains persist. We conclude with a discussion on principled innovation and collaborative efforts to further the mission of seamless integration of multimodal ML models into biomedical practice.

cs.LG

Explainable AI (XAI) in Biomedical Signal and Image Processing: Promises and Challenges

Artificial intelligence has become pervasive across disciplines and fields, and biomedical image and signal processing is no exception. The growing and widespread interest on the topic has triggered a vast research activity that is reflected in an exponential research effort. Through study of massive and diverse biomedical data, machine and deep learning models have revolutionized various tasks such as modeling, segmentation, registration, classification and synthesis, outperforming traditional techniques. However, the difficulty in translating the results into biologically/clinically interpretable information is preventing their full exploitation in the field. Explainable AI (XAI) attempts to fill this translational gap by providing means to make the models interpretable and providing explanations. Different solutions have been proposed so far and are gaining increasing interest from the community. This paper aims at providing an overview on XAI in biomedical data processing and points to an upcoming Special Issue on Deep Learning in Biomedical Image and Signal Processing of the IEEE Signal Processing Magazine that is going to appear in March 2022.

cs.LG

Efficient Inference of Spatially-varying Gaussian Markov Random Fields with Applications in Gene Regulatory Networks

In this paper, we study the problem of inferring spatially-varying Gaussian Markov random fields (SV-GMRF) where the goal is to learn a network of sparse, context-specific GMRFs representing network relationships between genes. An important application of SV-GMRFs is in inference of gene regulatory networks from spatially-resolved transcriptomics datasets. The current work on inference of SV-GMRFs are based on the regularized maximum likelihood estimation (MLE) and suffer from overwhelmingly high computational cost due to their highly nonlinear nature. To alleviate this challenge, we propose a simple and efficient optimization problem in lieu of MLE that comes equipped with strong statistical and computational guarantees. Our proposed optimization problem is extremely efficient in practice: we can solve instances of SV-GMRFs with more than 2 million variables in less than 2 minutes. We apply the developed framework to study how gene regulatory networks in Glioblastoma are spatially rewired within tissue, and identify prominent activity of the transcription factor HES4 and ribosomal proteins as characterizing the gene expression network in the tumor peri-vascular niche that is known to harbor treatment resistant stem cells.

stat.AP

Tumor Radiogenomics with Bayesian Layered Variable Selection

We propose a statistical framework to integrate radiological magnetic resonance imaging (MRI) and genomic data to identify the underlying radiogenomic associations in lower grade gliomas (LGG). We devise a novel imaging phenotype by dividing the tumor region into concentric spherical layers that mimics the tumor evolution process. MRI data within each layer is represented by voxel--intensity-based probability density functions which capture the complete information about tumor heterogeneity. Under a Riemannian-geometric framework these densities are mapped to a vector of principal component scores which act as imaging phenotypes. Subsequently, we build Bayesian variable selection models for each layer with the imaging phenotypes as the response and the genomic markers as predictors. Our novel hierarchical prior formulation incorporates the interior-to-exterior structure of the layers, and the correlation between the genomic markers. We employ a computationally-efficient Expectation--Maximization-based strategy for estimation. Simulation studies demonstrate the superior performance of our approach compared to other approaches. With a focus on the cancer driver genes in LGG, we discuss some biologically relevant findings. Genes implicated with survival and oncogenesis are identified as being associated with the spherical layers, which could potentially serve as early-stage diagnostic markers for disease monitoring, prior to routine invasive approaches.

stat.ME

RADIOHEAD: Radiogenomic Analysis Incorporating Tumor Heterogeneity in Imaging Through Densities

Recent technological advancements have enabled detailed investigation of associations between the molecular architecture and tumor heterogeneity, through multi-source integration of radiological imaging and genomic (radiogenomic) data. In this paper, we integrate and harness radiogenomic data in patients with lower grade gliomas (LGG), a type of brain cancer, in order to develop a regression framework called RADIOHEAD (RADIOgenomic analysis incorporating tumor HEterogeneity in imAging through Densities) to identify radiogenomic associations. Imaging data is represented through voxel intensity probability density functions of tumor sub-regions obtained from multimodal magnetic resonance imaging, and genomic data through molecular signatures in the form of pathway enrichment scores corresponding to their gene expression profiles. Employing a Riemannian-geometric framework for principal component analysis on the set of probability densities functions, we map each probability density to a vector of principal component scores, which are then included as predictors in a Bayesian regression model with the pathway enrichment scores as the response. Variable selection compatible with the grouping structure amongst the predictors induced through the tumor sub-regions is carried out under a group spike-and-slab prior. A Bayesian false discovery rate mechanism is then used to infer significant associations based on the posterior distribution of the regression coefficients. Our analyses reveal several pathways relevant to LGG etiology (such as synaptic transmission, nerve impulse and neurotransmitter pathways), to have significant associations with the corresponding imaging-based predictors.

stat.ME

Integrative Bayesian models using Post-selective Inference: a case study in Radiogenomics

Integrative analyses based on statistically relevant associations between genomics and a wealth of intermediary phenotypes (such as imaging) provide vital insights into their clinical relevance in terms of the disease mechanisms. Estimates for uncertainty in the resulting integrative models are however unreliable unless inference accounts for the selection of these associations with accuracy. In this article, we develop selection-aware Bayesian methods which: (i) counteract the impact of model selection bias through a "selection-aware posterior" in a flexible class of integrative Bayesian models post a selection of promising variables via $\ell_1$-regularized algorithms; (ii) strike an inevitable tradeoff between the quality of model selection and inferential power when the same dataset is used for both selection and uncertainty estimation. Central to our methodological development, a carefully constructed conditional likelihood function deployed with a reparameterization mapping provides notably tractable updates when gradient-based MCMC sampling is used for estimating uncertainties from the selection-aware posterior. Applying our methods to a radiogenomic analysis, we successfully recover several important gene pathways and estimate uncertainties for their associations with patient survival times.

stat.AP

Utilizing Automated Breast Cancer Detection to Identify Spatial Distributions of Tumor Infiltrating Lymphocytes in Invasive Breast Cancer

Quantitative assessment of Tumor-TIL spatial relationships is increasingly important in both basic science and clinical aspects of breast cancer research. We have developed and evaluated convolutional neural network (CNN) analysis pipelines to generate combined maps of cancer regions and tumor infiltrating lymphocytes (TILs) in routine diagnostic breast cancer whole slide tissue images (WSIs). We produce interactive whole slide maps that provide 1) insight about the structural patterns and spatial distribution of lymphocytic infiltrates and 2) facilitate improved quantification of TILs. We evaluated both tumor and TIL analyses using three CNN networks - Resnet-34, VGG16 and Inception v4, and demonstrated that the results compared favorably to those obtained by what believe are the best published methods. We have produced open-source tools and generated a public dataset consisting of tumor/TIL maps for 1,015 TCGA breast cancer images. We also present a customized web-based interface that enables easy visualization and interactive exploration of high-resolution combined Tumor-TIL maps for 1,015TCGA invasive breast cancer cases that can be downloaded for further downstream analyses.

eess.IV

Radiologic Image-based Statistical Shape Analysis of Brain Tumors

We propose a curve-based Riemannian-geometric approach for general shape-based statistical analyses of tumors obtained from radiologic images. A key component of the framework is a suitable metric that (1) enables comparisons of tumor shapes, (2) provides tools for computing descriptive statistics and implementing principal component analysis on the space of tumor shapes, and (3) allows for a rich class of continuous deformations of a tumor shape. The utility of the framework is illustrated through specific statistical tasks on a dataset of radiologic images of patients diagnosed with glioblastoma multiforme, a malignant brain tumor with poor prognosis. In particular, our analysis discovers two patient clusters with very different survival, subtype and genomic characteristics. Furthermore, it is demonstrated that adding tumor shape information into survival models containing clinical and genomic variables results in a significant increase in predictive power.

stat.AP

Statistical Tests for Large Tree-structured Data

We develop a general statistical framework for the analysis and inference of large tree-structured data, with a focus on developing asymptotic goodness-of-fit tests. We first propose a consistent statistical model for binary trees, from which we develop a class of invariant tests. Using the model for binary trees, we then construct tests for general trees by using the distributional properties of the Continuum Random Tree, which arises as the invariant limit for a broad class of models for tree-structured data based on conditioned Galton--Watson processes. The test statistics for the goodness-of-fit tests are simple to compute and are asymptotically distributed as $χ^2$ and $F$ random variables. We illustrate our methods on an important application of detecting tumour heterogeneity in brain cancer. We use a novel approach with tree-based representations of magnetic resonance images and employ the developed tests to ascertain tumor heterogeneity between two groups of patients.

math.ST

Inferring network structure in non-normal and mixed discrete-continuous genomic data

Inferring dependence structure through undirected graphs is crucial for uncovering the major modes of multivariate interaction among high-dimensional genomic markers that are potentially associated with cancer. Traditionally, conditional independence has been studied using sparse Gaussian graphical models for continuous data and sparse Ising models for discrete data. However, there are two clear situations when these approaches are inadequate. The first occurs when the data are continuous but display non-normal marginal behavior such as heavy tails or skewness, rendering an assumption of normality inappropriate. The second occurs when a part of the data is ordinal or discrete (e.g., presence or absence of a mutation) and the other part is continuous (e.g., expression levels of genes or proteins). In this case, the existing Bayesian approaches typically employ a latent variable framework for the discrete part that precludes inferring conditional independence among the data that are actually observed. The current article overcomes these two challenges in a unified framework using Gaussian scale mixtures. Our framework is able to handle continuous data that are not normal and data that are of mixed continuous and discrete nature, while still being able to infer a sparse conditional sign independence structure among the observed data. Extensive performance comparison in simulations with alternative techniques and an analysis of a real cancer genomics data set demonstrate the effectiveness of the proposed approach.

stat.ME

Identification and Query of Activated Gene Pathways in Disease Progression

Disease occurs due to aberrant expression of genes and modulation of the biological pathways along which they lie. Inference of activated gene pathways, using gene expression data during disease progression, is an important problem. In this work, we have developed a generalizable framework for the identification of interacting pathways while incorporating biological realism, using functional data analysis and manifold embedding techniques. Additionally, we have also developed a new method to query for the differential co-ordinated activity of any desired pathway during disease progression. The methods developed in this work can be generalized to any conditions of interest.

q-bio.GN